Fluoxetine Hydrochloride Patent Expiration

Fluoxetine Hydrochloride is Used for treating depression and minimizing nausea side effects. It was first introduced by Eli Lilly And Co in its drug Prozac on Dec 29, 1987. Other drugs containing Fluoxetine Hydrochloride are Prozac Weekly, Fluoxetine Hydrochloride, Sarafem. 56 different companies have introduced drugs containing Fluoxetine Hydrochloride.


Fluoxetine Hydrochloride Patents

Given below is the list of patents protecting Fluoxetine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Prozac US6960577 Combination therapy for treatment of refractory depression Nov 01, 2017

(Expired)

Eli Lilly And Co
Prozac Weekly US5910319 Fluoxetine enteric pellets and methods for their preparation and use May 29, 2017

(Expired)

Lilly
Prozac Weekly US5910319

(Pediatric)

Fluoxetine enteric pellets and methods for their preparation and use Nov 29, 2017

(Expired)

Lilly
Prozac Weekly US5985322 Method for the treatment of CNS disorders May 29, 2017

(Expired)

Lilly
Prozac Weekly US5985322

(Pediatric)

Method for the treatment of CNS disorders Nov 29, 2017

(Expired)

Lilly
Prozac Weekly USRE39030 Fluoxetine enteric pellets and methods for their preparation and use May 29, 2017

(Expired)

Lilly


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Fluoxetine Hydrochloride's patents.

Given below is the list recent legal activities going on the following patents of Fluoxetine Hydrochloride.

Event Date Patent/Publication
Patent litigations
Patent Issue Date Used in PTA Calculation 01 Nov, 2005 US6960577
Recordation of Patent Grant Mailed 01 Nov, 2005 US6960577
Issue Notification Mailed 12 Oct, 2005 US6960577
Receipt into Pubs 06 Oct, 2005 US6960577
Dispatch to FDC 05 Oct, 2005 US6960577
Application Is Considered Ready for Issue 13 Aug, 2005 US6960577
Issue Fee Payment Verified 05 Jul, 2005 US6960577
Issue Fee Payment Received 05 Jul, 2005 US6960577
Mail Examiner's Amendment 02 Jun, 2005 US6960577
Mail Notice of Allowance 02 Jun, 2005 US6960577



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Fluoxetine Hydrochloride Generics

Several generic applications have been filed for Fluoxetine Hydrochloride. The first generic version for Fluoxetine Hydrochloride was by Marksans Pharma Ltd and was approved on Aug 2, 2001. And the latest generic version is by Strides Pharma Global Pte Ltd and was approved on Apr 5, 2024.

Given below is the list of companies who have filed for Fluoxetine Hydrochloride generic.


1. TARO

Taro Pharmaceutical Industries Ltd has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 60MG BASE tablet Prescription ORAL AB Nov 21, 2018


2. BEXIMCO PHARMS USA

Beximco Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Beximco Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE capsule Discontinued ORAL N/A Jan 29, 2002
EQ 10MG BASE capsule Discontinued ORAL N/A Jan 29, 2002


3. GRANULES

Granules India Ltd has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Granules.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE capsule Discontinued ORAL N/A Jan 16, 2008
EQ 10MG BASE capsule Discontinued ORAL N/A Jan 16, 2008
EQ 20MG BASE capsule Discontinued ORAL N/A Jan 16, 2008


4. LANDELA PHARM

Landela Pharmaceutical has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Landela Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE capsule Prescription ORAL AB1 Jan 30, 2002
EQ 20MG BASE capsule Prescription ORAL AB1 Jan 30, 2002


5. NOSTRUM LABS INC

Nostrum Laboratories Inc has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Nostrum Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE/5ML solution Prescription ORAL AA Feb 7, 2002


6. PHARM ASSOC

Pharmaceutical Associates Inc has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Pharm Assoc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE/5ML

(reference standard)

solution Prescription ORAL AA Jan 30, 2002


7. CADILA PHARMS LTD

Cadila Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Cadila Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE capsule Prescription ORAL AB1 May 23, 2019
EQ 10MG BASE capsule Prescription ORAL AB1 May 23, 2019
EQ 40MG BASE capsule Prescription ORAL AB May 23, 2019


8. MICRO LABS

Micro Labs Ltd has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Micro Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE capsule Prescription ORAL AB Mar 29, 2022
EQ 10MG BASE capsule Prescription ORAL AB1 Mar 29, 2022
EQ 20MG BASE capsule Prescription ORAL AB1 Mar 29, 2022


9. BARR

Barr Laboratories Inc has filed for 4 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Barr.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE capsule Discontinued ORAL N/A Aug 2, 2001
EQ 10MG BASE tablet Discontinued ORAL N/A Feb 1, 2002
EQ 40MG BASE capsule Discontinued ORAL N/A May 18, 2005
EQ 90MG BASE capsule, delayed rel pellets Discontinued ORAL N/A Mar 24, 2010


10. TEVA

Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE/5ML solution Prescription ORAL AA Aug 2, 2001
EQ 10MG BASE capsule Prescription ORAL AB1 Jan 29, 2002
EQ 20MG BASE tablet Discontinued ORAL N/A Jan 4, 2019
EQ 40MG BASE capsule Prescription ORAL AB Jan 29, 2002


11. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE capsule Discontinued ORAL N/A Dec 16, 2004
EQ 20MG BASE tablet Prescription ORAL AB Apr 5, 2024
EQ 10MG BASE tablet Prescription ORAL AB Apr 5, 2024


12. LANNETT CO INC

Lannett Co Inc has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE/5ML solution Prescription ORAL AA Feb 9, 2007


13. HERITAGE PHARMS

Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Heritage Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE capsule Prescription ORAL AB1 Oct 1, 2012
EQ 20MG BASE capsule Prescription ORAL AB1 Oct 1, 2012
EQ 40MG BASE capsule Prescription ORAL AB Oct 1, 2012


14. FOSUN PHARMA

Fosun Pharma Usa Inc has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Fosun Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE tablet Discontinued ORAL N/A Jan 29, 2002


15. MARKSANS PHARMA

Marksans Pharma Ltd has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Marksans Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE capsule Prescription ORAL AB Aug 2, 2001
EQ 10MG BASE capsule Prescription ORAL AB1 Jan 29, 2002
EQ 20MG BASE capsule Prescription ORAL AB1 Jan 29, 2002


16. IVAX SUB TEVA PHARMS

Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Ivax Sub Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE capsule Prescription ORAL AB1 Jan 31, 2002
EQ 10MG BASE tablet Discontinued ORAL N/A Feb 28, 2002
EQ 40MG BASE capsule Prescription ORAL AB Sep 28, 2004


17. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE capsule Prescription ORAL AB1 Jan 31, 2008
EQ 20MG BASE capsule Prescription ORAL AB1 Jan 31, 2008
EQ 40MG BASE capsule Prescription ORAL AB Jan 31, 2008
EQ 20MG BASE/5ML solution Prescription ORAL AA Mar 20, 2009


18. G AND W LABS INC

G And W Laboratories Inc has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by G And W Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 60MG BASE tablet Discontinued ORAL N/A Jul 5, 2019


19. BAJAJ

Bajaj Medical Llc has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Bajaj.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE/5ML solution Discontinued ORAL N/A Jan 29, 2002


20. NATCO PHARMA USA

Natco Pharma Usa Llc has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Natco Pharma Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE capsule Discontinued ORAL N/A Nov 17, 2008
EQ 10MG BASE capsule Discontinued ORAL N/A Nov 17, 2008


21. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE tablet Prescription ORAL AB Apr 5, 2017
EQ 10MG BASE tablet Prescription ORAL AB Apr 5, 2017


22. TORRENT

Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Torrent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

(reference standard)

tablet Prescription ORAL N/A Oct 21, 2016
EQ 10MG BASE tablet Prescription ORAL N/A Oct 21, 2016


23. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Fluoxetine Hydrochloride. Out of these eq 20mg base version comes by the name SELFEMRA, eq 10mg base version comes by the name SELFEMRA, eq 15mg base version comes by the name SELFEMRA. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE tablet Discontinued ORAL N/A Feb 3, 2014
EQ 10MG BASE tablet Discontinued ORAL N/A Feb 3, 2014
EQ 15MG BASE tablet Discontinued ORAL N/A Feb 3, 2014
EQ 60MG BASE tablet Discontinued ORAL N/A Dec 3, 2018


24. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. All of these versions come by the name FLUOXETINE. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE capsule Discontinued ORAL N/A Jan 29, 2002
EQ 20MG BASE capsule Discontinued ORAL N/A Jan 29, 2002


25. LUPIN LTD

Lupin Ltd has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 60MG BASE tablet Prescription ORAL AB Feb 8, 2019
EQ 20MG BASE tablet Prescription ORAL AB Apr 15, 2019
EQ 10MG BASE tablet Prescription ORAL AB Apr 15, 2019


26. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE capsule Discontinued ORAL N/A Dec 13, 2004


27. INVENTIA HLTHCARE

Inventia Healthcare Private Ltd has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Inventia Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 60MG BASE tablet Prescription ORAL AB Nov 20, 2017


28. SLATE RUN PHARMA

Slate Run Pharmaceuticals Llc has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Slate Run Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE tablet Discontinued ORAL N/A Sep 13, 2022
EQ 10MG BASE tablet Discontinued ORAL N/A Sep 13, 2022


29. SAPTALIS PHARMS

Saptalis Pharmaceuticals Llc has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Saptalis Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE/5ML solution Discontinued ORAL N/A Jun 27, 2002


30. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE capsule Discontinued ORAL N/A Aug 27, 2020
EQ 40MG BASE capsule Discontinued ORAL N/A Aug 27, 2020
EQ 20MG BASE capsule Discontinued ORAL N/A Aug 27, 2020


31. SPECGX LLC

Specgx Llc has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Specgx Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE capsule Discontinued ORAL N/A Jan 29, 2002
EQ 20MG BASE capsule Discontinued ORAL N/A Jan 29, 2002


32. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 90MG BASE

(reference standard)

capsule, delayed rel pellets Prescription ORAL N/A Mar 22, 2010


33. SANDOZ

Sandoz Inc has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE capsule Discontinued ORAL N/A Nov 17, 2008
EQ 10MG BASE capsule Discontinued ORAL N/A Nov 17, 2008


34. ALEMBIC PHARMS LTD

Alembic Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE capsule Prescription ORAL AB1 Mar 19, 2009
EQ 40MG BASE capsule Prescription ORAL AB Mar 19, 2009
EQ 20MG BASE capsule Prescription ORAL AB1 Mar 19, 2009


35. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE tablet Prescription ORAL AB Mar 20, 2019
EQ 40MG BASE capsule Prescription ORAL AB Mar 16, 2015
EQ 10MG BASE tablet Prescription ORAL AB Mar 20, 2019
EQ 60MG BASE tablet Prescription ORAL AB Jan 10, 2019


36. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. All of these versions come by the name FLUOXETINE. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE capsule Discontinued ORAL N/A Jan 29, 2002
EQ 10MG BASE capsule Discontinued ORAL N/A Jan 29, 2002


37. NOVITIUM PHARMA

Novitium Pharma Llc has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Novitium Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE/5ML solution Prescription ORAL AA Nov 9, 2022


38. APTAPHARMA INC

Aptapharma Inc has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aptapharma Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE/5ML solution Prescription ORAL AA Nov 15, 2022


39. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE capsule Discontinued ORAL N/A Jan 29, 2002
EQ 20MG BASE capsule Discontinued ORAL N/A Jan 29, 2002


40. MYLAN

Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE capsule Discontinued ORAL N/A Jan 30, 2002
EQ 10MG BASE capsule Discontinued ORAL N/A Jan 30, 2002
EQ 40MG BASE capsule Discontinued ORAL N/A May 25, 2007


41. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE tablet Prescription ORAL AB Jan 30, 2002
EQ 20MG BASE

(reference standard)

tablet Prescription ORAL AB Apr 23, 2018
EQ 60MG BASE tablet Prescription ORAL AB Jan 25, 2019


42. RISING

Rising Pharma Holding Inc has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE tablet Discontinued ORAL N/A Aug 2, 2001
EQ 10MG BASE tablet Discontinued ORAL N/A Aug 2, 2001


43. ACTAVIS MID ATLANTIC

Actavis Mid Atlantic Llc has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE/5ML solution Discontinued ORAL N/A Jan 31, 2002


44. ANI PHARMS

Ani Pharmaceuticals Inc has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Ani Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE capsule Discontinued ORAL N/A May 20, 2008
EQ 20MG BASE capsule Discontinued ORAL N/A May 20, 2008


45. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE/5ML solution Discontinued ORAL N/A May 14, 2004


46. UPSHER SMITH LABS

Upsher Smith Laboratories Llc has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE tablet Discontinued ORAL N/A Jan 30, 2019
EQ 10MG BASE tablet Discontinued ORAL N/A Jan 30, 2019


47. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE tablet Prescription ORAL AB Apr 8, 2020
EQ 20MG BASE tablet Prescription ORAL AB Apr 8, 2020
EQ 60MG BASE tablet Prescription ORAL AB Jun 10, 2020


48. CR DOUBLE CRANE

China Resources Double Crane Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Cr Double Crane.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE capsule Discontinued ORAL N/A Feb 1, 2002
EQ 10MG BASE capsule Discontinued ORAL N/A Feb 1, 2002


49. ENDO OPERATIONS

Endo Operations Ltd has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE tablet Prescription ORAL AB Aug 19, 2016
EQ 10MG BASE tablet Prescription ORAL AB Aug 19, 2016
EQ 60MG BASE tablet Prescription ORAL AB Nov 16, 2017


50. APNAR PHARMA LP

Apnar Pharma Lp has filed for 3 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Apnar Pharma Lp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE capsule Prescription ORAL AB1 Aug 2, 2001
EQ 20MG BASE capsule Prescription ORAL AB1 Jan 29, 2002
EQ 40MG BASE capsule Prescription ORAL AB Jan 29, 2002


51. CARLSBAD

Carlsbad Technology Inc has filed for 2 different strengths of generic version for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Carlsbad.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE capsule Discontinued ORAL N/A Jan 30, 2002
EQ 10MG BASE capsule Discontinued ORAL N/A Jan 30, 2002


52. PHARMOBEDIENT CNSLTG

Pharmobedient Consulting has filed for 1 generic for Fluoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Pharmobedient Cnsltg.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE/5ML solution Discontinued ORAL N/A Aug 29, 2002